On February 19, 2026 ALX Oncology Holdings Inc. ("ALX Oncology"; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, reported that ALX Oncology leadership will participate in the Wells Fargo Executive Biotech Summit, TD Cowen 46th Annual Health Care Conference, and UBS Biotech Summit.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The details of the meetings are as follows:

Wells Fargo Executive Biotech Summit

Format: One-on-one meetings
Date: February 24-25, 2026
Location: Lake Tahoe, CA

TD Cowen 46th Annual Health Care Conference

Format: Presentation
Date: March 3, 2026
Time: 9:10 AM EST
Location: Boston, MA
Webcast link: Available here

UBS Biotech Summit

Format: One-on-one meetings
Date: March 10, 2026
Location: Miami, FL

The webcast of the TD Cowen 46th Annual Health Care Conference presentation can be accessed by visiting the Investors section of ALX Oncology’s website at www.alxoncology.com under the Events section of the Events and Presentations tab. Replay of the webcast will be archived for up to 90 days following the presentation date.

(Press release, ALX Oncology, FEB 19, 2026, View Source [SID1234662779])